tiprankstipranks
Claritas Pharmaceuticals Inc (CLAZF)
:CLAZF
US Market

Claritas Pharmaceuticals (CLAZF) Income Statement

Compare
25 Followers

Claritas Pharmaceuticals Income Statement

Last quarter (Q3 2023), Claritas Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Claritas Pharmaceuticals's net income was $0.00. See Claritas Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 0.00$ 0.00$ -184.00K$ 9.45M
Depreciation and Amortization
$ 228.49K$ 236.56K$ -184.00K$ 9.45M
EBITDA
$ 0.00$ 0.00$ -2.79M$ -9.50M
Operating Income
$ 0.00$ 0.00$ -3.28M$ -25.88M
Other Income/Expenses
$ 0.00$ 0.00$ -858.00K$ -16.38M
Pretax Income
$ 0.00$ 0.00$ -674.00K$ -25.83M
Net Income
$ 0.00$ 0.00$ 4.21M$ -21.21M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ 0.00$ 0.00$ 0.17$ -0.95
Diluted EPS
$ 0.00$ 0.00$ 0.17$ -0.95
Weighted Average Shares Outstanding
0.00 0.00 26.69M 22.44M
Weighted Average Shares Outstanding (Diluted)
0.00 0.00 26.69M 22.44M
Currency in USD

Claritas Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis